Pharmexcil wants input on tax laws relating to Indian Pharma exports
The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has called on members to make suggestions for changes to tax laws governing pharmaceutical exports ahead of India’s next budget, reports In-Pharma Technologist.com.
According to a letter posted on the Pharmexcil web site, the Indian Department of Commerce is seeking Pre-Budget Proposals for 2013-14 from the pharmaceutical Industry, which the organization thinks is a good opportunity for the sector.
“Since it would be [the] right opportunity to make suggestions for inclusion/deletion/modifications of any Direct and Indirect Taxes in the Union Budget for 2013-14, members are requested to send their proposals…which will be compiled and forwarded to the Department of Commerce for their consideration and recommendations to Finance.” The deadline for submission is September 30, said In-Pharma.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
More on this story...
Today's issue
Company Spotlight
More Features in Generics
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze